Markets

Market

News Details

(03/02/2026 19:00)

Biogen Pharmachem - Board Meeting Intimation for Reschedule Board Meeting As Per Compliance Of Regulation 29 Of SEBI (LODR) R

Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 ,inter alia, to consider and approve Pursuant to regulation 29(1)(d) and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, we wish to inform you that the meeting of Board of Director of the Company which is going to be held today 3rd February 2026 stands postponed due to unavoidable circumstances and rescheduled on Wednesday 11th February 2026. inter alia, to consider following business. -\r\n\r\n1.) To approve and take on record the Un-Audited Financial Results of the Company for the quarter and nine months ended as on 31st December 2025.\r\n\r\n2.) Any other matter with the permission of the board which the Board may think fit.\r\n\r\nPlease take the above intimation in your records.\r\n\r\nThanking You\r\n

Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.